| Toxicity | Start Regimen in which Toxicity Occurred | Responsible Medication | Frequency | Percentage (%) |
|---|---|---|---|---|
| Peripheral neuropathy | D4T+3TC+NVP | DT4 | 13 | 47.1% |
| D4T+3TC+EFV | D4T | 3 | ||
| Severe rash | AZT+3TC+NVP | NVP | 7 | 20.6% |
| Anemia | AZT+3TC+NVP | AZT | 4 | 14.7% |
| AZT+3TC+EFV | AZT | 1 | ||
| Hepatotoxicity | AZT+3TC+NVP | NVP | 3 | 8.8% |
| CNS complication | TDF+3TC+EFV | EFV | 2 | 5.9% |
| Nephrotoxicity | TDF+3TC+EFV | TDF | 1 | 2.9% |